Search

everythinglearnresearchcommunity

for

Search:↓

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

AH-001 could be a safer and more effective treatment for hair loss.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Granulocyte colony stimulating factor helps heal wounds without scars.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

The study aims to find the best platelet-rich plasma dose to relieve moderate carpal tunnel syndrome symptoms.

Combining PRP with CGF is more effective for hair regrowth in androgenetic alopecia than PRP alone.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Promising cancer treatments were found, but the manufacturer closed.

Cells from concentrated growth factor can become different cell types.

Total glucosides of paeony may help treat alopecia areata by reducing inflammation and hair loss.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Diagnosing and managing Glucocorticoid Resistance Syndrome is complex due to genetic differences and varied symptoms.

Block and replace therapy improved symptoms in recurrent cyclic Cushing’s disease.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

TAK-279 effectively reduces psoriasis symptoms and is safe.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Blocking prolactin increases the activity of secondary hair follicles in cashmere goats.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Blocking CXCL12 can reverse hair loss and fibrosis in androgenetic alopecia.

Cell membrane-coated nanoparticles could improve gene therapy by enhancing delivery and targeting of nucleic acids.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.